Stride Settles With Activist Fivespan, Adds Two Directors and Launches Capital Allocation Review
LRN sits 34% above its 52-week low of $60.615.
Summary
Stride settled an activist campaign by Fivespan Partners, adding two new directors and forming a Capital Allocation Committee that will announce a target capital structure within three months.
Key Events · Executive and Board Changes · LRN
-
Activist Settlement With Fivespan
Stride entered a Cooperation Agreement with Fivespan Partners, ending the investor's proxy contest, director nominations, shareholder proposal, and Section 220 books-and-records demand.
-
Two New Directors Appointed
Dylan Haggart (Fivespan founder) joins the board effective October 30, 2026, and Dr. Steven Guttentag (former CEO of EPS Learning) becomes a board observer immediately and a director after the 2026 Annual Meeting.
-
Capital Allocation Committee Formed
A new committee co-chaired by Brian Shepherd and Dylan Haggart will review capital structure and allocation strategy, with a public announcement of target capital structure expected within three months.
-
Board Reshuffling
Director Allison Lawrence resigned effective before Haggart's appointment but will be re-appointed after the 2026 Annual Meeting; the board will expand from eight to ten directors, nine of whom will be independent.
Analysis · LRN · Trade & Services
Stride has resolved a brewing proxy fight with activist investor Fivespan Partners by agreeing to add Fivespan founder Dylan Haggart and education technology veteran Dr. Steven Guttentag to its board, and by forming a Capital Allocation Committee that will publicly announce a target capital structure within three months. The agreement ends Fivespan's director nominations, shareholder proposal, and books-and-records demand, and imposes standstill and voting commitments on the investor group. For shareholders, the key near-term question is what the committee recommends: Stride already has a $311M buyback in place, and an activist with a seat at the table could push for a larger return of capital, a dividend, or a change in acquisition strategy. The board will expand from eight to ten directors after the December 10, 2026 annual meeting, with nine independent directors.
How filings like this one have moved
In the 30 days to Oct 9, 2026, 36.7% of the 1061 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.62%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LRN was trading at $81.36 on NYSE in the Trade & Services sector, with a market capitalization of approximately $3.4B. The 52-week trading range was $60.61 to $155.06. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.